Zhang Boli
首页 > 学术活动 > 专家风采

Zhang Boli

Professor, doctoral supervisor, Academician of Chinese Academy of Engineering, President of the China Academy of Chinese Medical Sciences and President of the Tianjin University of Traditional Chinese Medicine. He is Technological Vice chief engineer of the National Major Scientific and Technological Special Project for “Significant New Drugs Development”, Member of the Consulting Expert Committee on Healthcare System Reform of the State Council, the academic leader of internal medicine of TCM, Honorary President of the China Association of Integrative Medicine, Vice President of Chinese Medical Association, Vice President of the China Association of Traditional Chinese Medicine, Director of the National Chinese Medicine Teaching Advisory Board of the Ministry of Education, Director of the Educational Instruction Committee of World Federation of Chinese Medicine Societies.

He mainly devoted to the research of preventing and treating cardiovascular and cerebrovascular diseases and the modernization of TCM. He completed systematic researches on vascular dementia (VD) and formulated the classification standard of VD symptoms and a treatment scheme for three-phase of VD, including platform, fluctuating and gliding phase. He specified the TCM symptoms of stroke and dynamic evolution of premonitory symptoms, and developed comprehensive therapeutic schedule. He developed pharmacological method of cerebrospinal fluid (CSF) and the illustrated the protection mechanism of Chinese material medica for neurocyte. He has continuously hold three national basic research program of China (973 program) and developed the new method to R&D of the modern Chinese drugs with component-based compatibility.
He has completed the first lager scale randomized clinical trial of Chinese patent medicine for the secondary prevention of myocardial infarction, and built the methods and key technology of evidence-based evaluation on Chinese medicine. He opened up the secondary exploitation field of Chinese patent medicine, which cultured a large group of big-market drugs and promote the technological upgrading of Chinese Medicine Industry.
He has won seven national science and technology awards and more than 20 provincial and ministerial scientific and technological progress awards. He has been delivered more than 200 papers. He has cultivated more than 180 post-doctoral students and postgraduates.